Preventive vaccines are biological products that reduce the risk of infectious diseases by working with a person's immune system either to prevent infections or reduce severity of disease. Vaccines contain antigens from viruses or bacteria and work by stimulating the immune system to develop antibodies against the antigen such that when the body encounters the actual pathogen, immunity has already been achieved. The global preventive vaccines market is estimated to be valued at US$ 51057.26 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
Growing awareness regarding disease prevention

The market opportunity lies in the growing awareness regarding prevention of infectious diseases through immunization. Preventive vaccines help provide protection against potentially life threatening diseases by allowing the body to safely develop immunity against various pathogens. As knowledge about vaccine preventable diseases increases, more people are voluntarily opting for vaccination of themselves as well as their family members. This rising vaccination awareness especially in developing countries will boost the demand for preventive vaccines market over the forecast period. Government initiatives aimed at disseminating information about vaccine benefits will further contribute to increased adoption of immunization programs around the world. This growing awareness regarding disease prevention through immunization presents lucrative opportunities for preventive vaccines market players.

Porter's Analysis

Threat of new entrants: New entrants face high entry barriers in the form of stringent regulations and high capital requirements for R&D and clinical trials.

Bargaining power of buyers: Buyers have moderate bargaining power as preventive vaccines are necessity goods and switching costs are high.

Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiation in technologies and patented products.

Threat of new substitutes: Substitutes have low threat as preventive vaccines are irreplaceable for immunity and disease prevention.

Competitive rivalry: Intense as key players compete on innovation, patents and new product launches.

SWOT Analysis

Strengths: High demand driven by disease outbreaks and initiatives by governments and global health organizations. Large untapped potential in developing regions.

Weaknesses: High R&D costs, regulatory approvals and clinical trials. Supply disruptions and challenges emerging from the pandemic.

Opportunities: Growing geriatric population and chronic diseases. Collaborations for new product development and market expansion in emerging countries.

Threats: Pricing pressures. Safety issues and recall of existing vaccines causing revenue losses. Delays in regulatory approvals.

Key Takeaways

The global Preventive Vaccines Market Growth size is expected to witness high growth at a CAGR of 9.4% during the forecast period of 2023-2030. North America is expected to remain the dominant regional market due to supportive regulatory environment and presence of key players. The Asia Pacific region is anticipated to register fastest growth owing to large population base, improving healthcare infrastructure and growing awareness.

Regional analysis: The Asia Pacific region is projected to offer lucrative growth opportunities owing to widening vaccination coverage under national programs in India and China. Growing per capita spending on healthcare and rising healthcare infrastructure will further drive the APAC preventive vaccines market during the forecast period.

Key players: Key players operating in the preventive vaccines market are Sanofi SA, Pfizer Inc., Novavax Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline PLC, Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., AstraZeneca, and Takeda Pharmaceutical Company Limited, among others. Major players focus on new product launches, expansions and collaborations to strengthen their market position.

For more insights, read- https://www.pressreleasebulletin.com/preventive-vaccines-market-trends-size-and-share-analysis-2/